WMSA
IONS icon

Weiss Multi-Strategy Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$863K – 443
2015
Q2 		$863K Buy
15,000
+10,000
+200% +$636K 0.03% 327
2015
Q1 		$318K Buy
+5,000
New +$339K 0.01% 395

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IONS Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 5,073 shares — an estimated $202K sold.

Weiss Multi-Strategy Advisers first reported a position in IONS in Q4 2013 and held it in 14 quarters. The position peaked at $1.29M in Q3 2018. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Weiss Multi-Strategy Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 5,073 Ionis Pharmaceuticals shares in Q3 2021, an estimated $202K.
  • Weiss Multi-Strategy Advisers first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • Weiss Multi-Strategy Advisers's Ionis Pharmaceuticals position peaked at $1.29M in Q3 2018.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.